| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7504423 | Drug and Alcohol Dependence | 2015 | 9 Pages |
Abstract
Buspirone was not more efficacious than placebo in reducing cannabis use. Important gender differences were noted, with women having worse cannabis use outcomes with buspirone treatment. Considerations for future medication trials in this challenging population are discussed.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Aimee L. McRae-Clark, Nathaniel L. Baker, Kevin M. Gray, Therese K. Killeen, Amanda M. Wagner, Kathleen T. Brady, C. Lindsay DeVane, Jessica Norton,